Searcharxiv⌕ Search

arXiv subjects

Liesbeth Vancoillie

Publications and source records attributed to Liesbeth Vancoillie.

3 recordsLinked to original sources

Demographic Distribution Matching between real world and virtual phantom population

Virtual imaging trials (VITs) offer scalable and cost-effective tools for evaluating imaging systems and protocols. However, their translational impact depends on rigorous comparability between virtual and real-world populations. This study introduces DISTINCT (Distributional Subsampling for Covariate-Targeted Alignment), a statistical framework for selecting demographically aligned subsamples from large clinical datasets to support robust comparisons with virtual cohorts. We applied DISTINCT to the National Lung Screening Trial (NLST) and a companion virtual trial dataset (VLST). The algorithm jointly aligned typical continuous (age, BMI) and categorical (sex, race, ethnicity) variables by constructing multidimensional bins based on discretized covariates. For a given target size, DISTINCT samples individuals to match the joint demographic distribution of the reference population. We evaluated the demographic similarity between VLST and progressively larger NLST subsamples using Wasserstein and Kolmogorov-Smirnov (K-S) distances to identify the maximal subsample size with acceptable alignment. The algorithm identified a maximal aligned NLST subsample of 9,974 participants, preserving demographic similarity to the VLST population. Receiver operating characteristic (ROC) analysis using risk scores for lung cancer detection showed that area under the curve (AUC) estimates stabilized beyond 6,000 participants, confirming the sufficiency of aligned subsamples for virtual imaging trial evaluation. Stratified AUC analysis revealed substantial performance variation across demographic subgroups, reinforcing the importance of covariate alignment in comparative studies.

stat.AP↗

Virtual Lung Screening Trial (VLST): An In Silico Study Inspired by the National Lung Screening Trial for Lung Cancer Detection

Clinical imaging trials play a crucial role in advancing medical innovation but are often costly, inefficient, and ethically constrained. Virtual Imaging Trials (VITs) present a solution by simulating clinical trial components in a controlled, risk-free environment. The Virtual Lung Screening Trial (VLST), an in silico study inspired by the National Lung Screening Trial (NLST), illustrates the potential of VITs to expedite clinical trials, minimize risks to participants, and promote optimal use of imaging technologies in healthcare. This study aimed to show that a virtual imaging trial platform could investigate some key elements of a major clinical trial, specifically the NLST, which compared Computed tomography (CT) and chest radiography (CXR) for lung cancer screening. With simulated cancerous lung nodules, a virtual patient cohort of 294 subjects was created using XCAT human models. Each virtual patient underwent both CT and CXR imaging, with deep learning models, the AI CT-Reader and AI CXR-Reader, acting as virtual readers to perform recall patients with suspicion of lung cancer. The primary outcome was the difference in diagnostic performance between CT and CXR, measured by the Area Under the Curve (AUC). The AI CT-Reader showed superior diagnostic accuracy, achieving an AUC of 0.92 (95% CI: 0.90-0.95) compared to the AI CXR-Reader's AUC of 0.72 (95% CI: 0.67-0.77). Furthermore, at the same 94% CT sensitivity reported by the NLST, the VLST specificity of 73% was similar to the NLST specificity of 73.4%. This CT performance highlights the potential of VITs to replicate certain aspects of clinical trials effectively, paving the way toward a safe and efficient method for advancing imaging-based diagnostics.

eess.IV↗

Proceedings Virtual Imaging Trials in Medicine 2024

This submission comprises the proceedings of the 1st Virtual Imaging Trials in Medicine conference, organized by Duke University on April 22-24, 2024. The listed authors serve as the program directors for this conference. The VITM conference is a pioneering summit uniting experts from academia, industry and government in the fields of medical imaging and therapy to explore the transformative potential of in silico virtual trials and digital twins in revolutionizing healthcare. The proceedings are categorized by the respective days of the conference: Monday presentations, Tuesday presentations, Wednesday presentations, followed by the abstracts for the posters presented on Monday and Tuesday.

physics.med-ph↗